Perturb-seq uncovers pathological obstacles to direct cardiac reprogramming in vivo

Journal:
Cell Stem Cell
Published:
DOI:
10.1016/j.stem.2026.03.006
Affiliations:
2
Authors:
8
Go to article
Institutions Authors Share
State Key Laboratory of Natural and Biomimetic Drugs, PKU, China
4.500000
 0.56
Tsinghua - PKU Joint Center for Life Sciences (CLS), China
3.500000
 0.44
Interested in Medical Biotechnology?